Metformin Shows Promise in Alopecia
A recent retrospective case series suggests that metformin, a commonly prescribed medication for type 2 diabetes, may also significantly improve symptoms and promote hair regrowth
FDA Offers Advice on Safe Dosing Practices for Diabetes Medications
The U.S. Food and Drug Administration (FDA) has issued a warning to both patients and healthcare providers regarding dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes
Are Current Surgical Fasting Guidelines Adequate for Diabetic Patients?
Recent research suggests that people with diabetes do not need to fast longer before surgery compared to those without diabetes. This study, led by a team of anesthesiologists, found
Mounjaro Takes the Lead Over Ozempic
A new study reveals that Eli Lilly’s Mounjaro significantly outperforms Novo Nordisk’s Ozempic in promoting weight loss, despite both drugs sharing similar side effects and dropout rates.
Maximizing Weight Loss with Wegovy and Other Weight Loss Medications
When it comes to managing your health, medication choices can be confusing, especially when you’re faced with the decision between generic and brand-name drugs. Understanding the differences, benefits, and considerations
How New Diabetes Drugs Have The Potential To Lower Stroke Risk
Recent advancements in antidiabetic therapies have introduced new drugs that not only manage blood sugar levels but also show promise in reducing stroke risk. Unlike traditional therapies, these newer medications
Novo Nordisk Attributes High Prices of Weight-Loss Drugs to U.S. Healthcare Middlemen
Novo Nordisk, the Danish pharmaceutical company, has attributed the high prices of its popular weight-loss drugs, Wegovy and Ozempic, to middlemen within the U.S. healthcare system. This response comes amidst
Ozempic’s Role in Modern Diabetes Care, Efficacy, Safety, and Savings
Ozempic (semaglutide) has revolutionized diabetes care with its potent efficacy and safety in controlling blood sugar levels and aiding weight loss. This article explores Ozempic’s transformative impact, examining its
Wegovy Lands in Canada Paving the Way for Enhanced Obesity Management
Wegovy, a weight-loss medication developed by the creators of Ozempic, is set to launch in Canada on Monday, May 2/2024. Novo Nordisk’s new weekly injection is designed for individuals diagnosed
The Current Weight-Loss Drug Market
In the dynamic arena of pharmaceuticals, Novo Nordisk and Eli Lilly have surged ahead in the competitive race for a share of the burgeoning weight-loss drugs market, anticipated to soar
Diabetes Management Through Nutrition
Managing diabetes involves paying close attention to your diet to control blood sugar levels. Navigating the realm of nutrition can be particularly daunting for individuals managing diabetes. With blood sugar
Medications That May Be Affecting Blood Glucose Levels
Maintaining stable blood glucose levels is crucial for individuals with diabetes as well as those at risk of developing the condition. While diet and lifestyle play significant roles, certain medications
The Challenge of Type 2 Diabetes Remission Through Weight Loss
New research suggests that only a small percentage of individuals with type 2 diabetes (T2D) manage to achieve and maintain diabetes remission through weight loss alone. Among over 37,000 individuals
Diet Considerations While Taking Ozempic
For decades, statins like atorvastatin (Lipitor) have reigned supreme as the go-to treatment for high cholesterol. Yet, as with any medical regimen, one size does not fit all.
A Comprehensive Guide to Diabetic Neuropathy
Diabetic neuropathy, a common complication of diabetes, presents a formidable challenge for those living with the condition. Characterized by nerve damage resulting from prolonged periods of elevated blood sugar levels,